EyePoint Pharmaceuticals Inc (EYPT) concluded trading on Thursday at a closing price of $17.50, with 4.14 million shares of worth about $72.48 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 117.66% during that period and on April 18, 2024 the price saw a loss of about -16.43%. Currently the company’s common shares owned by public are about 49.04M shares, out of which, 46.63M shares are available for trading.
However, the stock later moved at a day high price of 20.79, or with a loss of -16.43%. Stock saw a price change of -23.55% in past 5 days and over the past one month there was a price change of -20.81%. Year-to-date (YTD), EYPT shares are showing a performance of -24.28% which increased to 255.69% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $4.45 but also hit the highest price of $30.99 during that period. The average intraday trading volume for EyePoint Pharmaceuticals Inc shares is 925.92K. The stock is currently trading -18.21% below its 20-day simple moving average (SMA20), while that difference is down -28.05% for SMA50 and it goes to 10.06% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) currently have 49.04M outstanding shares and institutions hold larger chunk of about 96.21% of that.
The stock has a current market capitalization of $872.02M and its 3Y-monthly beta is at 1.67. It has posted earnings per share of -$1.84 in the same period. It has Quick Ratio of 5.39 while making debt-to-equity ratio of 0.02. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for EYPT, volatility over the week remained 9.86% while standing at 6.61% over the month.
Stock’s fiscal year EPS is expected to rise by 7.02% while it is estimated to decrease by -53.79% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by JP Morgan on January 22, 2024 offering an Overweight rating for the stock and assigned a target price of $35 to it. Coverage by Mizuho stated EyePoint Pharmaceuticals Inc (EYPT) stock as a Buy in their note to investors on November 02, 2023, suggesting a price target of $20 for the stock. On April 21, 2023, Robert W. Baird Initiated their recommendations, while on July 07, 2022, Chardan Capital Markets Initiated their ratings for the stock with a price target of $21. Stock get an Outperform rating from Cowen on March 01, 2021.
